Four categories of statin-induced myopathy can be distinguished: myositis, self-limited toxic statin myopathy, myalgia or increased creatine kinase, and rhabdomyolysis (i.e. the recently described IMNM with anti-HMGCR antibodies) [6]. The gene discussed is HMGCR; the disease is myopathy.